← 產業報告目錄

Enteral Feeding Devices Market by Type (Feeding Tubes (NG, NJ, OG, Gastronomy), Pumps: Feeding, Syringes; Consumables), Age (Neonates, Pediatric, Adult), Application (Oncology, GIT, Neuro, Diabetes), End User (Hospitals, Home, ASC) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-05-15頁數 302報告編號 MD1289

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global market for enteral feeding devices is projected to reach USD 3,994.2 million by 2030, from USD 2,965.1 million in 2025. This expansion is largely driven by advancements in medical technology, which have made enteral feeding systems safer, more effective, and easier for caregivers and family members to manage. Rigorous specifications from healthcare authorities ensure that these systems meet high standards of safety and efficiency. Other factors contributing to market growth include competition within the industry, demographic shifts, economic factors, globalization, patient-centered design, digital integration, and sustainability considerations. “Enteral feeding tubes to be largest segment during forecast period” The enteral feeding tubes segment is projected to hold the largest share of the enteral feeding devices market between 2025 and 2030. Key factors driving this trend include the increased prevalence of chronic illnesses, the rise in geriatric population, rapid advancements in technology, a surge in home health care, pediatric applications, heightened awareness of nutritional management, compliance with regulations, and increased health care spending. Manufacturers will need to innovate flexibly to meet diverse patient needs while ensuring safety and usability in various clinical settings, influenced by the global evolution of these factors. “Oncology to surpass other applications during forecast period” In 2024, the oncology segment accounted for the largest share of the enteral feeding devices market, and this trend is expected to continue during the forecast period. The factors influencing enteral feeding practices in oncology include nutritional support for the cancer treatment patient, enhanced recovery after surgery protocol, management of cancer-related malnutrition, technological advances, individualized nutritional planning, integration of enteral feeding with palliative care, economic issues, regulatory support, patient education, and other related ongoing research and development. These factors facilitate the effective utilization of enteral feeding to enhance the patient’s quality of life and outcomes pertaining to a cancer diagnosis.   “Hospitals & surgical centers segment to be prevalent during forecast period” Hospitals & surgical centers are expected to be the largest segment in the enteral feeding devices market during the forecast period. The increasing use of enteral feeding in these facilities is primarily due to its positive impact on patient outcomes and the resulting cost savings in healthcare. Other contributing factors include compliance with regulations, advancements in technology, enhancements in patient safety and comfort, increased awareness and education about enteral feeding, integration with electronic health records (EHR), government initiatives, patient-centered care models, and collaboration among healthcare professionals. As these factors evolve, enteral feeding will continue to play a crucial role in patient care in hospitals and surgical centers. “Asia Pacific to register significant growth during forecast period” The Asia Pacific region, comprising Japan, India, China, South Korea, Australia, and the Rest of Asia Pacific, is anticipated to experience substantial growth during the forecast period. The region has experienced a notable acceleration in the market growth rate for enteral feeding devices. Contributing factors include demographic changes, economic growth, increased affordability, advancements in technology, regulatory frameworks, improved healthcare awareness, the expansion of healthcare services, enhanced trade and market access, and various government initiatives. Together, these factors create a highly dynamic market that fosters innovation and growth opportunities for both local and international companies. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30% • By Designation: C-level -- 27%, Director-level – 18%, and Others – 55% • By Region: North America – 50%, Europe – 20%, Asia Pacific – 15%, Latin America – 10%, and Middle East & Africa – 5% Prominent players in this market are Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others.   Research Coverage • The report studies the enteral feeding devices market based on product, age group, application, end user, and region. • The report analyzes drivers, restraints, opportunities, and challenges affecting the market growth. • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. • The report studies micro markets with respect to their growth trends, prospects, and contributions to the overall market. • The report forecasts the revenue of market segments with respect to five major regions. Key Benefits of Buying this Report: The report aims to assist new entrants, smaller firms, and market leaders in evaluating investment opportunities within the enteral feeding devices market. It offers a thorough analysis of comprehensive data, enabling informed investment decisions and effective risk assessment. By providing detailed market segmentation that includes end-user categories and regional considerations, the report offers tailored insights for precise targeting of specific segments. Additionally, it delivers an extensive evaluation of key trends, challenges, growth factors, and opportunities, empowering strategic decision-making with a clear understanding. The report provides insights on the following pointers: • Market Dynamics: Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enteral feeding devices market • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product & service launches in the enteral feeding devices market • Market Development: Comprehensive information about lucrative markets • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the enteral feeding devices market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others
目錄 Table of Contents
1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE 28 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 28 1.3.2 INCLUSIONS AND EXCLUSIONS 29 1.3.3 YEARS CONSIDERED 29 1.4 CURRENCY CONSIDERED 30 1.5 STAKEHOLDERS 30 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 2.1.1 SECONDARY RESEARCH 33 2.1.1.1 List of secondary sources 33 2.1.1.2 Key data from secondary sources 34 2.1.1.3 Objectives of secondary research 34 2.1.2 PRIMARY RESEARCH 35 2.1.2.1 List of primary sources (demand and supply sides) 35 2.1.2.2 Supply- and demand-side participants 35 2.1.2.3 Breakdown of primary interviews (supply side) 36 2.1.2.4 Breakdown of primary interviews (demand side) 36 2.1.2.5 Objectives of primary research 36 2.2 MARKET SIZE ESTIMATION 37 2.2.1 BOTTOM-UP APPROACH 38 2.2.1.1 Approach 1: Company revenue estimation 39 2.2.1.2 Approach 2: Customer-based market estimation 39 2.2.1.3 Approach 3: Primary interviews 40 2.2.2 TOP-DOWN APPROACH 40 2.3 GROWTH FORECAST ASSUMPTIONS 42 2.4 DATA TRIANGULATION 44 2.5 RESEARCH ASSUMPTIONS 45 2.6 RESEARCH LIMITATIONS 45 2.7 RISK ASSESSMENT 45 3 EXECUTIVE SUMMARY 46   4 PREMIUM INSIGHTS 50 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ENTERAL FEEDING DEVICES MARKET 50 4.2 ENTERAL FEEDING DEVICES MARKET, BY REGION 51 4.3 US ENTERAL FEEDING DEVICES MARKET, BY COUNTRY AND END USER 52 4.4 ENTERAL FEEDING DEVICES MARKET, BY COUNTRY 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 5.2.1 DRIVERS 55 5.2.1.1 Benefits and cost-effectiveness of enteral nutrition 55 5.2.1.2 High incidence of preterm births and genetic disorders in pediatric and neonatal patients 55 5.2.1.3 Rapid growth in geriatric population and age-related chronic diseases 56 5.2.1.4 Increasing prevalence of dysphagia 58 5.2.2 RESTRAINTS 58 5.2.2.1 Complications associated with enteral feeding devices 58 5.2.2.2 Lack of awareness about feeding tubes 61 5.2.3 OPPORTUNITIES 61 5.2.3.1 High growth opportunities in emerging economies 61 5.2.3.2 Growing demand for enteral feeding in home care settings 62 5.2.4 CHALLENGES 62 5.2.4.1 Insufficient reimbursement policies in emerging economies 62 5.2.4.2 Shortage of endoscopy specialists 63 5.3 PORTER’S FIVE FORCES ANALYSIS 64 5.3.1 THREAT OF NEW ENTRANTS 65 5.3.2 THREAT OF SUBSTITUTES 65 5.3.3 BARGAINING POWER OF SUPPLIERS 65 5.3.4 BARGAINING POWER OF BUYERS 65 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 65 5.4 REGULATORY LANDSCAPE 66 5.4.1 REGULATORY ANALYSIS 66 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 5.5 REIMBURSEMENT SCENARIO 69 5.6 ECOSYSTEM ANALYSIS 69 5.7 INVESTMENT AND FUNDING SCENARIO 70 5.8 TECHNOLOGY ANALYSIS 71 5.8.1 KEY TECHNOLOGIES 71 5.8.1.1 Flow generation mechanisms 71 5.8.1.2 Flow control technologies 72 5.8.2 COMPLEMENTARY TECHNOLOGIES 72 5.8.2.1 Smart feeding pumps 72 5.8.2.2 Feeding tube replacement technologies 72 5.8.3 ADJACENT TECHNOLOGIES 72 5.8.3.1 Patient monitoring systems 72 5.8.3.2 Digital connectivity 73 5.8.3.3 Nutrition supplements 73 5.9 VALUE CHAIN ANALYSIS 73 5.9.1 RESEARCH AND DEVELOPMENT 73 5.9.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING 74 5.9.3 DISTRIBUTION, MARKETING AND SALES, AND AFTER-SALES SERVICES 74 5.10 SUPPLY CHAIN ANALYSIS 75 5.10.1 PROMINENT COMPANIES 75 5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES 75 5.10.3 END USERS 76 5.11 PRICING ANALYSIS 76 5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 77 5.11.2 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES OFFERED BY KEY PLAYERS 79 5.11.3 AVERAGE SELLING PRICE TREND, BY REGION 83 5.12 PATENT ANALYSIS 85 5.13 TRADE ANALYSIS 87 5.13.1 IMPORT SCENARIO (HS CODE 901839) 87 5.13.2 EXPORT SCENARIO (HS CODE 901839) 88 5.14 KEY CONFERENCES AND EVENTS, 2025–2026 89 5.15 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 90 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 91 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 91 5.16.2 BUYING CRITERIA 92 5.17 UNMET NEEDS AND KEY PAIN POINTS 93 5.18 IMPACT OF AI ON ENTERAL FEEDING DEVICES MARKET 94 6 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT 95 6.1 INTRODUCTION 96 6.2 ENTERAL FEEDING TUBES 96 6.2.1 NASAL FEEDING TUBES 100 6.2.1.1 Need for short-term feeding with minimal tube replacement to drive market 100 6.2.2 ORAL FEEDING TUBES 103 6.2.2.1 Extensive use in feeding preterm babies to drive market 103 6.2.3 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) 106 6.2.3.1 Escalating demand for PEG and PRG tubes to drive market 106   6.2.4 JEJUNOSTOMY TUBES (J-TUBES) 110 6.2.4.1 Trend of minimally invasive procedures to drive market 110 6.2.5 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) 113 6.2.5.1 Reduced tube dislodgment and user-friendly feeding to drive market 113 6.3 ENTERAL FEEDING PUMPS 116 6.3.1 RAPID GROWTH IN HOME HEALTHCARE TO DRIVE MARKET 116 6.4 ENTERAL SYRINGE PUMPS 120 6.4.1 RELIANCE ON TUBE FEEDING TO DRIVE MARKET 120 6.5 CONSUMABLES & ACCESSORIES 123 6.5.1 SYRINGES 127 6.5.1.1 Technological improvements to drive market 127 6.5.2 EXTENSION SETS 129 6.5.2.1 Safe and flexible delivery of nutrition, fluids, and medications to drive market 129 6.5.3 ADAPTERS 132 6.5.3.1 Focus on biocompatible materials and minimally invasive designs to drive market 132 6.5.4 NUTRITION STRAWS 134 6.5.4.1 Emergence of home enteral nutrition programs to drive market 134 7 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP 137 7.1 INTRODUCTION 138 7.2 NEONATAL PATIENTS 138 7.2.1 RISE IN PRETERM BIRTHS TO DRIVE MARKET 138 7.3 PEDIATRIC PATIENTS 139 7.3.1 HEIGHTENED CONCERNS OF MALNUTRITION TO DRIVE MARKET 139 7.4 ADULT PATIENTS 140 7.4.1 HIGH BURDEN OF CHRONIC DISEASES TO DRIVE MARKET 140 7.5 GERIATRIC PATIENTS 141 7.5.1 DEMOGRAPHIC TRENDS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET 141 8 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION 143 8.1 INTRODUCTION 144 8.2 ONCOLOGY 144 8.2.1 INCREASED PREVALENCE OF CANCER TO DRIVE MARKET 144 8.3 GASTROINTESTINAL DISORDERS 146 8.3.1 RISE OF IRRITABLE BOWEL SYNDROME AND GASTROESOPHAGEAL REFLUX DISEASE TO DRIVE MARKET 146 8.4 NEUROLOGICAL DISORDERS 147 8.4.1 SURGE IN DEMAND FOR CLINICAL NUTRITION THERAPIES TO DRIVE MARKET 147 8.5 DIABETES 148 8.5.1 NEED FOR CONTROLLED ADMINISTRATION OF MEDICATIONS TO DRIVE MARKET 148 8.6 METABOLIC DISORDERS 150 8.6.1 GROWING INCIDENCE OF BURN INJURIES AND SEPSIS TO DRIVE MARKET 150 8.7 OTHER APPLICATIONS 151 9 ENTERAL FEEDING DEVICES MARKET, BY END USER 153 9.1 INTRODUCTION 154 9.2 HOSPITALS & SURGICAL CENTERS 154 9.2.1 RAPID ADOPTION OF ENTERAL FEEDING DEVICES IN INTENSIVE CARE UNITS TO DRIVE MARKET 154 9.3 HOME CARE 155 9.3.1 SUBSTANTIAL HOSPITALIZATION COSTS TO DRIVE MARKET 155 9.4 AMBULATORY CARE SETTINGS 156 9.4.1 ELEVATED DEMAND FOR SPECIALTY CARE TO DRIVE MARKET 156 9.5 OTHER END USERS 157 10 ENTERAL FEEDING DEVICES MARKET, BY REGION 159 10.1 INTRODUCTION 160 10.2 NORTH AMERICA 160 10.2.1 MACROECONOMIC OUTLOOK 161 10.2.2 US 164 10.2.2.1 Presence of major enteral feeding device providers to drive market 164 10.2.3 CANADA 166 10.2.3.1 Increasing incidence of chronic diseases such as diabetes and cancer to drive market 166 10.3 EUROPE 167 10.3.1 MACROECONOMIC OUTLOOK 167 10.3.2 GERMANY 170 10.3.2.1 Government initiatives enhancing domestic healthcare system to drive market 170 10.3.3 FRANCE 171 10.3.3.1 Escalating demand for early disease diagnosis to drive market 171 10.3.4 UK 173 10.3.4.1 Substantial rise in cancer and neurological disorders to drive market 173 10.3.5 ITALY 174 10.3.5.1 Elevated demand for cost-effective home care solutions to drive market 174 10.3.6 SPAIN 175 10.3.6.1 Surge in patients opting for enteral nutrition to drive market 175 10.3.7 REST OF EUROPE 177 10.4 ASIA PACIFIC 178 10.4.1 MACROECONOMIC OUTLOOK 178 10.4.2 CHINA 182 10.4.2.1 Growing investments in healthcare infrastructure development to drive market 182 10.4.3 JAPAN 184 10.4.3.1 Rapidly expanding geriatric population to drive market 184 10.4.4 INDIA 185 10.4.4.1 Large patient pool and increased per capita income to drive market 185 10.4.5 AUSTRALIA 187 10.4.5.1 Soaring volume of patients to drive market 187 10.4.6 SOUTH KOREA 188 10.4.6.1 Large number of private hospitals to drive market 188 10.4.7 REST OF ASIA PACIFIC 189 10.5 LATIN AMERICA 190 10.5.1 MACROECONOMIC OUTLOOK 190 10.5.2 BRAZIL 192 10.5.2.1 Improving healthcare facilities to drive market 192 10.5.3 MEXICO 194 10.5.3.1 Robust healthcare system with universal health coverage to drive growth 194 10.5.4 REST OF LATIN AMERICA 195 10.6 MIDDLE EAST & AFRICA 196 10.6.1 MACROECONOMIC OUTLOOK 197 10.6.2 GCC COUNTRIES 199 10.6.3 REST OF MIDDLE EAST & AFRICA 200 11 COMPETITIVE LANDSCAPE 201 11.1 INTRODUCTION 201 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024 201 11.3 REVENUE ANALYSIS, 2020–2024 203 11.4 MARKET SHARE ANALYSIS, 2024 203 11.4.1 ENTERAL FEEDING TUBES MARKET SHARE 204 11.4.2 ENTERAL FEEDING PUMPS MARKET SHARE 204 11.4.3 ENTERAL SYRINGE PUMPS MARKET SHARE 205 11.4.4 CONSUMABLES & ACCESSORIES MARKET SHARE 205 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 208 11.5.1 STARS 208 11.5.2 EMERGING LEADERS 208 11.5.3 PERVASIVE PLAYERS 208 11.5.4 PARTICIPANTS 208 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 210 11.5.5.1 Company footprint 210 11.5.5.2 Region footprint 211 11.5.5.3 Product footprint 212 11.5.5.4 Application footprint 213 11.5.5.5 Age group footprint 214 11.5.5.6 End user footprint 215 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024 216 11.6.1 PROGRESSIVE COMPANIES 216 11.6.2 RESPONSIVE COMPANIES 216 11.6.3 DYNAMIC COMPANIES 216 11.6.4 STARTING BLOCKS 216 11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024 218 11.6.5.1 List of start-ups/SMEs 218 11.6.5.2 Competitive benchmarking of start-ups/SMEs 219 11.7 COMPANY VALUATION AND FINANCIAL METRICS 220 11.8 PRODUCT/BRAND COMPARISON 221 11.9 COMPETITIVE SCENARIO 222 11.9.1 PRODUCT LAUNCHES AND APPROVALS 222 11.9.2 DEALS 223 12 COMPANY PROFILES 225 12.1 KEY PLAYERS 225 12.1.1 FRESENIUS SE & CO. KGAA 225 12.1.1.1 Business overview 225 12.1.1.2 Products offered 226 12.1.1.3 Recent developments 227 12.1.1.3.1 Expansions 227 12.1.1.3.2 Other developments 228 12.1.1.4 MnM view 228 12.1.1.4.1 Key strengths 228 12.1.1.4.2 Strategic choices 228 12.1.1.4.3 Weaknesses and competitive threats 228 12.1.2 CARDINAL HEALTH 229 12.1.2.1 Business overview 229 12.1.2.2 Products offered 230 12.1.2.3 Recent developments 231 12.1.2.3.1 Product launches and approvals 231 12.1.2.3.2 Deals 232 12.1.2.4 MnM view 232 12.1.2.4.1 Key strengths 232 12.1.2.4.2 Strategic choices 233 12.1.2.4.3 Weaknesses and competitive threats 233 12.1.3 NESTLÉ S.A. 234 12.1.3.1 Business overview 234 12.1.3.2 Products offered 235 12.1.3.3 MnM view 236 12.1.3.3.1 Key strengths 236 12.1.3.3.2 Strategic choices 237 12.1.3.3.3 Weaknesses and competitive threats 237 12.1.4 AVANOS MEDICAL, INC. 238 12.1.4.1 Business overview 238 12.1.4.2 Products offered 239 12.1.4.3 Recent developments 242 12.1.4.3.1 Product launches and approvals 242 12.1.4.3.2 Expansions 242 12.1.4.4 MnM view 242 12.1.4.4.1 Key strengths 242 12.1.4.4.2 Strategic choices 243 12.1.4.4.3 Weaknesses and competitive threats 243 12.1.5 DANONE S.A. 244 12.1.5.1 Business overview 244 12.1.5.2 Products offered 245 12.1.5.3 Recent developments 246 12.1.5.3.1 Deals 246 12.1.5.4 MnM view 247 12.1.5.4.1 Key strengths 247 12.1.5.4.2 Strategic choices 247 12.1.5.4.3 Weaknesses and competitive threats 247 12.1.6 BOSTON SCIENTIFIC CORPORATION 248 12.1.6.1 Business overview 248 12.1.6.2 Products offered 249 12.1.6.3 Recent developments 250 12.1.6.3.1 Deals 250 12.1.6.3.2 Expansions 251 12.1.7 BECTON, DICKINSON AND COMPANY 252 12.1.7.1 Business overview 252 12.1.7.2 Products offered 253 12.1.7.3 Recent developments 255 12.1.7.3.1 Product launches and approvals 255 12.1.8 B. BRAUN MELSUNGEN AG 256 12.1.8.1 Business overview 256 12.1.8.2 Products offered 257 12.1.9 CONMED CORPORATION 259 12.1.9.1 Business overview 259 12.1.9.2 Products offered 260 12.1.9.3 Recent developments 261 12.1.9.3.1 Deals 261   12.1.10 COOK MEDICAL 262 12.1.10.1 Business overview 262 12.1.10.2 Products offered 263 12.1.11 MOOG, INC. 265 12.1.11.1 Business overview 265 12.1.11.2 Products offered 266 12.1.12 BAXTER INTERNATIONAL INC. 268 12.1.12.1 Business overview 268 12.1.12.2 Products offered 269 12.1.12.3 Recent developments 270 12.1.12.3.1 Deals 270 12.1.13 VYGON 271 12.1.13.1 Business overview 271 12.1.13.2 Products offered 271 12.1.13.3 Recent developments 273 12.1.13.3.1 Deals 273 12.1.14 ENTERAL ACCESS TECHNOLOGIES LTD. 274 12.1.14.1 Business overview 274 12.1.14.2 Products offered 274 12.1.14.3 Recent developments 275 12.1.14.3.1 Other developments 275 12.1.15 FIDMI MEDICAL 276 12.1.15.1 Business overview 276 12.1.15.2 Products offered 276 12.1.15.3 Recent developments 277 12.1.15.3.1 Product launches and approvals 277 12.1.16 LIFEPUM MEDITECH 278 12.1.16.1 Business overview 278 12.1.16.2 Products offered 278 12.2 OTHER PLAYERS 279 12.2.1 APPLIED MEDICAL TECHNOLOGY, INC. 279 12.2.2 AMSINO INTERNATIONAL, INC. 280 12.2.3 OMEX MEDICAL TECHNOLOGY 282 12.2.4 DANUMED MEDIZINTECHNIK GMBH. 283 12.2.5 MEDLINE INDUSTRIES 284 12.2.6 FUJI SYSTEMS CORPORATION 285 12.2.7 KENTEC MEDICAL. 286 12.2.8 DYNAREX CORPORATION 287 12.2.9 VESCO MEDICAL, LLC 288 12.2.10 MEDELA AG 289 12.2.11 ALCOR SCIENTIFIC 290 12.2.12 ROMSONS 291 13 APPENDIX 293 13.1 DISCUSSION GUIDE 293 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 297 13.3 CUSTOMIZATION OPTIONS 299 13.4 RELATED REPORTS 300 13.5 AUTHOR DETAILS 301
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 30 TABLE 2 US: TOTAL NUMBER OF PRETERM BIRTHS, 2015–2021 55 TABLE 3 DIABETIC POPULATION, BY REGION, 2021 VS. 2030 VS. 2045 56 TABLE 4 GLOBAL CANCER INCIDENCE, 2015–2040 57 TABLE 5 US: GERIATRIC POPULATION, 2022–2050 (MILLION) 57 TABLE 6 COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING DEVICES 59 TABLE 7 PORTER’S FIVE FORCES ANALYSIS 64 TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 13 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 69 TABLE 14 AVERAGE SELLING PRICE TREND OF G-TUBES OFFERED BY KEY PLAYERS, 2022–2024 (USD) 79 TABLE 15 AVERAGE SELLING PRICE TREND OF J-TUBES OFFERED BY KEY PLAYERS, 2022–2024 (USD) 80 TABLE 16 AVERAGE SELLING PRICE TREND OF NUTRITION STRAWS OFFERED BY KEY PLAYERS, 2022–2024 (USD) 81 TABLE 17 AVERAGE SELLING PRICE TREND OF ENTERAL SYRINGES OFFERED BY KEY PLAYERS, 2022–2024 (USD) 82 TABLE 18 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY REGION, 2022–2024 (USD) 83 TABLE 19 PATENT ANALYSIS 86 TABLE 20 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 88 TABLE 21 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 89 TABLE 22 KEY CONFERENCES AND EVENTS, 2025–2026 89 TABLE 23 KEY REQUIREMENTS OF STAKEHOLDERS WHEN BUYING ENTERAL FEEDING DEVICES 91 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE (%) 92 TABLE 25 BUYING CRITERIA FOR TOP THREE END USERS (%) 93 TABLE 26 UNMET CUSTOMER NEEDS AND KEY PAIN POINTS 93 TABLE 27 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 96 TABLE 28 ENTERAL FEEDING TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 97 TABLE 29 ENTERAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 30 NORTH AMERICA: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 31 EUROPE: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 32 ASIA PACIFIC: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 33 LATIN AMERICA: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 34 MIDDLE EAST & AFRICA: ENTERAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 35 ENTERAL FEEDING TUBES MARKET, BY END USER, 2023–2030 (USD MILLION) 99 TABLE 36 MAJOR BRANDS OF NASAL FEEDING TUBES AVAILABLE IN MARKET 100 TABLE 37 NASAL FEEDING TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 101 TABLE 38 NASAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 101 TABLE 39 NORTH AMERICA: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 40 EUROPE: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 41 ASIA PACIFIC: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 42 LATIN AMERICA: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 43 MIDDLE EAST & AFRICA: NASAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 44 ORAL FEEDING TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 104 TABLE 45 ORAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 46 NORTH AMERICA: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 47 EUROPE: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 48 ASIA PACIFIC: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 49 LATIN AMERICA: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 50 MIDDLE EAST & AFRICA: ORAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 51 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY TYPE, 2023–2030 (USD MILLION) 107 TABLE 52 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 53 NORTH AMERICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 54 EUROPE: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 55 ASIA PACIFIC: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 56 LATIN AMERICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 57 MIDDLE EAST & AFRICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 58 JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY TYPE, 2023–2030 (USD MILLION) 110 TABLE 59 JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 60 NORTH AMERICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 61 EUROPE: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 62 ASIA PACIFIC: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 63 LATIN AMERICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 64 MIDDLE EAST & AFRICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 65 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY TYPE, 2023–2030 (USD MILLION) 114 TABLE 66 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 67 NORTH AMERICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 68 EUROPE: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 69 ASIA PACIFIC: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 70 LATIN AMERICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 71 MIDDLE EAST & AFRICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY REGION, 2023–2030 (USD MILLION) 116 TABLE 72 MAJOR BRANDS OF ENTERAL FEEDING PUMPS AVAILABLE IN MARKET 117 TABLE 73 ENTERAL FEEDING PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 74 NORTH AMERICA: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 75 EUROPE: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 76 ASIA PACIFIC: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 77 LATIN AMERICA: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 78 MIDDLE EAST & AFRICA: ENTERAL FEEDING PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 79 ENTERAL FEEDING PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 120 TABLE 80 ENTERAL SYRINGE PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 81 NORTH AMERICA: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY 2023–2030 (USD MILLION) 121 TABLE 82 EUROPE: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 83 ASIA PACIFIC: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 84 LATIN AMERICA: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 85 MIDDLE EAST & AFRICA: ENTERAL SYRINGE PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 86 ENTERAL SYRINGE PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 123 TABLE 87 MAJOR BRANDS OF CONSUMABLES AVAILABLE IN MARKET 123 TABLE 88 CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 124 TABLE 89 CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 90 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 91 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 92 ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 93 LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 94 MIDDLE EAST & AFRICA: CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 95 CONSUMABLES & ACCESSORIES MARKET, BY END USER, 2023–2030 (USD MILLION) 127 TABLE 96 SYRINGES MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 97 NORTH AMERICA: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 98 EUROPE: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 99 ASIA PACIFIC: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 100 LATIN AMERICA: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 101 MIDDLE EAST & AFRICA: SYRINGES MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 102 EXTENSION SETS MARKET, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 103 NORTH AMERICA: EXTENSION SETS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 104 EUROPE: EXTENSION SETS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 105 ASIA PACIFIC: EXTENSION SETS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 106 LATIN AMERICA: EXTENSION SETS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 107 MIDDLE EAST & AFRICA: EXTENSION SETS MARKET, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 108 ADAPTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 109 NORTH AMERICA: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 110 EUROPE: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 111 ASIA PACIFIC: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 112 LATIN AMERICA: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 113 MIDDLE EAST & AFRICA: ADAPTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 114 NUTRITION STRAWS MARKET, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 115 NORTH AMERICA: NUTRITION STRAWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 116 EUROPE: NUTRITION STRAWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 117 ASIA PACIFIC: NUTRITION STRAWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 118 LATIN AMERICA: NUTRITION STRAWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 119 MIDDLE EAST & AFRICA: NUTRITION STRAWS MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 120 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2023–2030 (USD MILLION) 138 TABLE 121 NEONATAL PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 122 PEDIATRIC PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 123 ADULT PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 124 GERIATRIC PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 125 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 144 TABLE 126 ONCOLOGY: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 127 LIST OF DIGESTIVE SYSTEM-RELATED DISEASES/DISORDERS 146 TABLE 128 GASTROINTESTINAL DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 129 NEUROLOGICAL DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 130 NEW DIABETES CASES, BY COUNTRY, 2022 149 TABLE 131 TOP 10 COUNTRIES WITH HIGHEST PROPORTION OF PATIENTS WITH TYPE 1 DIABETES 150 TABLE 132 DIABETES: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 133 METABOLIC DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 134 OTHER APPLICATIONS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 135 ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 136 HOSPITALS & SURGICAL CENTERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 137 HOME CARE: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 138 AMBULATORY CARE SETTINGS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 139 OTHER END USERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 140 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 141 NORTH AMERICA: MACROECONOMIC OUTLOOK 161 TABLE 142 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 143 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 163 TABLE 144 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 145 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 146 US: KEY MACRO INDICATORS 165 TABLE 147 US: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165 TABLE 148 CANADA: KEY MACRO INDICATORS 166 TABLE 149 CANADA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 167 TABLE 150 EUROPE: MACROECONOMIC OUTLOOK 168 TABLE 151 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 152 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 153 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 154 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 155 GERMANY: KEY MACRO INDICATORS 171 TABLE 156 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171 TABLE 157 FRANCE: KEY MACRO INDICATORS 172 TABLE 158 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 172 TABLE 159 UK: KEY MACRO INDICATORS 173 TABLE 160 UK: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 174 TABLE 161 ITALY: KEY MACRO INDICATORS 175 TABLE 162 ITALY: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 175 TABLE 163 SPAIN: KEY MACRO INDICATORS 176 TABLE 164 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 176 TABLE 165 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177 TABLE 166 ASIA PACIFIC: MACROECONOMIC OUTLOOK 179 TABLE 167 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 168 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 181 TABLE 169 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182 TABLE 170 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 171 CHINA: KEY MACRO INDICATORS 183 TABLE 172 CHINA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 184 TABLE 173 JAPAN: KEY MACRO INDICATORS 185 TABLE 174 JAPAN: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 185 TABLE 175 INDIA: KEY MACRO INDICATORS 186 TABLE 176 INDIA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 187 TABLE 177 AUSTRALIA: KEY MACRO INDICATORS 187 TABLE 178 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 179 SOUTH KOREA: KEY MACRO INDICATORS 189 TABLE 180 SOUTH KOREA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 189 TABLE 181 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190 TABLE 182 LATIN AMERICA: MACROECONOMIC OUTLOOK 191 TABLE 183 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 184 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 191 TABLE 185 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 192 TABLE 186 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 187 BRAZIL: KEY MACRO INDICATORS 193 TABLE 188 BRAZIL: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193 TABLE 189 MEXICO: KEY MACRO INDICATORS 194 TABLE 190 MEXICO: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 195 TABLE 191 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196 TABLE 192 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 197 TABLE 193 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 197 TABLE 194 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 198 TABLE 195 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 198 TABLE 196 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 199 TABLE 197 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199 TABLE 198 REST OF MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 200 TABLE 199 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024 201 TABLE 200 ENTERAL FEEDING DEVICES MARKET: DEGREE OF COMPETITION 206 TABLE 201 REGION FOOTPRINT 211 TABLE 202 PRODUCT FOOTPRINT 212 TABLE 203 APPLICATION FOOTPRINT 213 TABLE 204 AGE GROUP FOOTPRINT 214 TABLE 205 END USER FOOTPRINT 215 TABLE 206 LIST OF START-UPS/SMES 218 TABLE 207 COMPETITIVE BENCHMARKING OF START-UPS/SMES 219 TABLE 208 ENTERAL FEEDING DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025 222 TABLE 209 ENTERAL FEEDING DEVICES MARKET: DEALS, JANUARY 2021–APRIL 2025 223 TABLE 210 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW 225 TABLE 211 FRESENIUS SE & CO. KGAA: PRODUCTS OFFERED 226 TABLE 212 FRESENIUS SE & CO. KGAA: EXPANSIONS 227 TABLE 213 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS 228 TABLE 214 CARDINAL HEALTH: COMPANY OVERVIEW 229 TABLE 215 CARDINAL HEALTH: PRODUCTS OFFERED 230 TABLE 216 CARDINAL HEALTH: PRODUCT LAUNCHES AND APPROVALS 231 TABLE 217 CARDINAL HEALTH: DEALS 232 TABLE 218 NESTLÉ S.A.: COMPANY OVERVIEW 234 TABLE 219 NESTLÉ S.A.: PRODUCTS OFFERED 235 TABLE 220 AVANOS MEDICAL, INC.: COMPANY OVERVIEW 238 TABLE 221 AVANOS MEDICAL, INC.: PRODUCTS OFFERED 239 TABLE 222 AVANOS MEDICAL, INC.: PRODUCT LAUNCHES AND APPROVALS 242 TABLE 223 AVANOS MEDICAL, INC.: EXPANSIONS 242 TABLE 224 DANONE S.A.: COMPANY OVERVIEW 244 TABLE 225 DANONE S.A.: PRODUCTS OFFERED 245 TABLE 226 DANONE S.A.: DEALS 246 TABLE 227 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 248 TABLE 228 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 249 TABLE 229 BOSTON SCIENTIFIC CORPORATION: DEALS 250 TABLE 230 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS 251 TABLE 231 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 252 TABLE 232 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 253 TABLE 233 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS 255 TABLE 234 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 256 TABLE 235 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 257 TABLE 236 CONMED CORPORATION: COMPANY OVERVIEW 259 TABLE 237 CONMED CORPORATION: PRODUCTS OFFERED 260 TABLE 238 CONMED CORPORATION: DEALS 261 TABLE 239 COOK MEDICAL: COMPANY OVERVIEW 262 TABLE 240 COOK MEDICAL: PRODUCTS OFFERED 263 TABLE 241 MOOG, INC.: COMPANY OVERVIEW 265 TABLE 242 MOOG, INC.: PRODUCTS OFFERED 266 TABLE 243 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW 268 TABLE 244 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED 269 TABLE 245 BAXTER INTERNATIONAL INC.: DEALS 270 TABLE 246 VYGON: COMPANY OVERVIEW 271 TABLE 247 VYGON: PRODUCTS OFFERED 271 TABLE 248 VYGON: DEALS 273 TABLE 249 ENTERAL ACCESS TECHNOLOGIES LTD.: COMPANY OVERVIEW 274 TABLE 250 ENTERAL ACCESS TECHNOLOGIES LTD.: PRODUCTS OFFERED 274 TABLE 251 ENTERAL ACCESS TECHNOLOGIES LTD.: OTHER DEVELOPMENTS 275 TABLE 252 FIDMI MEDICAL: COMPANY OVERVIEW 276 TABLE 253 FIDMI MEDICAL: PRODUCTS OFFERED 276 TABLE 254 FIDMI MEDICAL: PRODUCT LAUNCHES AND APPROVALS 277 TABLE 255 LIFEPUM MEDITECH: COMPANY OVERVIEW 278 TABLE 256 LIFEPUM MEDITECH: PRODUCTS OFFERED 278 TABLE 257 APPLIED MEDICAL TECHNOLOGY, INC.: COMPANY OVERVIEW 279 TABLE 258 AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW 280 TABLE 259 OMEX MEDICAL TECHNOLOGY: COMPANY OVERVIEW 282 TABLE 260 DANUMED MEDIZINTECHNIK GMBH: COMPANY OVERVIEW 283 TABLE 261 MEDLINE INDUSTRIES: COMPANY OVERVIEW 284 TABLE 262 FUJI SYSTEMS CORPORATION: COMPANY OVERVIEW 285 TABLE 263 KENTEC MEDICAL.: COMPANY OVERVIEW 286 TABLE 264 DYNAREX CORPORATION: COMPANY OVERVIEW 287 TABLE 265 VESCO MEDICAL, LLC: COMPANY OVERVIEW 288 TABLE 266 MEDELA AG: COMPANY OVERVIEW 289 TABLE 267 ALCOR SCIENTIFIC: COMPANY OVERVIEW 290 TABLE 268 ROMSONS: COMPANY OVERVIEW 291 FIGURE 1 ENTERAL FEEDING DEVICES MARKET SEGMENTATION 28 FIGURE 2 RESEARCH DATA 32 FIGURE 3 RESEARCH DESIGN 33 FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 37 FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38 FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 39 FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY 40 FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 41 FIGURE 9 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACRO INDICATORS 43 FIGURE 10 DATA TRIANGULATION 44 FIGURE 11 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 46 FIGURE 12 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 47 FIGURE 13 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2025 VS. 2030 (USD MILLION) 47 FIGURE 14 ENTERAL FEEDING DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 48 FIGURE 15 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2025–2030 49 FIGURE 16 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 50 FIGURE 17 ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR ENTERAL FEEDING DEVICES DURING FORECAST PERIOD 51 FIGURE 18 HOSPITALS & SURGICAL CENTERS AND US WERE LARGEST SEGMENTS IN 2024 52 FIGURE 19 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 53 FIGURE 20 ENTERAL FEEDING DEVICES MARKET DYNAMICS 54 FIGURE 21 ADOPTION OF ENTERAL FEEDING TUBES IN PATIENTS SUFFERING FROM PRADER–WILLIE SYNDROME (2024) 56 FIGURE 22 PORTER’S FIVE FORCES ANALYSIS 64 FIGURE 23 ECOSYSTEM ANALYSIS 70 FIGURE 24 INVESTMENT AND FUNDING SCENARIO, 2019–2023 (USD MILLION) 70 FIGURE 25 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 71 FIGURE 26 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 71 FIGURE 27 VALUE CHAIN ANALYSIS 75 FIGURE 28 SUPPLY CHAIN ANALYSIS 76 FIGURE 29 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING TUBES, BY TYPE, 2022–2024 (USD) 77 FIGURE 30 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY TYPE, 2022–2024 (USD) 78 FIGURE 31 AVERAGE SELLING PRICE TREND OF G-TUBES OFFERED BY KEY PLAYERS, 2022–2024 (USD) 79 FIGURE 32 AVERAGE SELLING PRICE TREND OF J-TUBES OFFERED BY KEY PLAYERS, 2022–2024 (USD) 80 FIGURE 33 AVERAGE SELLING PRICE TREND OF NUTRITION STRAWS OFFERED BY KEY PLAYERS, 2022–2024 (USD) 81 FIGURE 34 AVERAGE SELLING PRICE TREND OF ENTERAL SYRINGES OFFERED BY KEY PLAYERS, 2022–2024 (USD) 82 FIGURE 35 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY REGION, 2022–2024 (USD) 83 FIGURE 36 PATENT ANALYSIS 85 FIGURE 37 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 87 FIGURE 38 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 88 FIGURE 39 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 90 FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 91 FIGURE 41 KEY BUYING CRITERIA FOR TOP THREE END USERS 92 FIGURE 42 AGE-STANDARDIZED RATE OF CANCER, BY REGION, 2022 145 FIGURE 43 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET SNAPSHOT 162 FIGURE 44 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET SNAPSHOT 180 FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 203 FIGURE 46 ENTERAL FEEDING TUBES MARKET SHARE ANALYSIS, 2024 204 FIGURE 47 ENTERAL FEEDING PUMPS MARKET SHARE ANALYSIS, 2024 204 FIGURE 48 ENTERAL SYRINGE PUMPS MARKET SHARE ANALYSIS, 2024 205 FIGURE 49 CONSUMABLES & ACCESSORIES MARKET SHARE ANALYSIS, 2024 205 FIGURE 50 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 209 FIGURE 51 COMPANY FOOTPRINT 210 FIGURE 52 COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024 217 FIGURE 53 EV/EBITDA OF KEY VENDORS 220 FIGURE 54 5-YEAR STOCK BETA OF KEY VENDORS 220 FIGURE 55 BRAND/PRODUCT COMPARATIVE ANALYSIS 221 FIGURE 56 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT 226 FIGURE 57 CARDINAL HEALTH: COMPANY SNAPSHOT 230 FIGURE 58 NESTLÉ S.A.: COMPANY SNAPSHOT 235 FIGURE 59 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT 239 FIGURE 60 DANONE S.A.: COMPANY SNAPSHOT 245 FIGURE 61 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 249 FIGURE 62 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 253 FIGURE 63 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 257 FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT 260 FIGURE 65 COOK MEDICAL: COMPANY SNAPSHOT 263 FIGURE 66 MOOG, INC.: COMPANY SNAPSHOT 266 FIGURE 67 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT 269

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們